Evidence map›Paper›PMID 35817848›Full record

ArticleExperimental & molecular medicine2022

Cardiac-specific overexpression of Ndufs1 ameliorates cardiac dysfunction after myocardial infarction by alleviating mitochondrial dysfunction and apoptosis.

Bingchao Qi, Liqiang Song, Lang Hu, Dong Guo, Gaotong Ren, Tingwei Peng, Mingchuan Liu, Yexian Fang, Chunyu Li, Mingming Zhang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Experimental & molecular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 134 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. HM568 Enhances NADMolecular neurobiology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Bingchao Qi *Department of Cardiology, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, People's Republic of China.
Liqiang Song *Department of Pulmonary and Critical Care Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
Lang Hu *Department of Cardiology, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, People's Republic of China.
Dong GuoDepartment of Cardiology, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, People's Republic of China.
Gaotong RenDepartment of Cardiology, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, People's Republic of China.
Tingwei PengDepartment of Cardiology, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, People's Republic of China.
Mingchuan LiuDepartment of Cardiology, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, People's Republic of China.
Yexian FangDepartment of Cardiology, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, People's Republic of China.
Chunyu LiDepartment of Cardiology, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, People's Republic of China.
Mingming ZhangDepartment of Cardiology, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, People's Republic of China. winterzhang3@163.com.ORCID http://orcid.org/0000-0001-8480-0280
Yan LiDepartment of Cardiology, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, People's Republic of China. profleeyan@163.com.ORCID http://orcid.org/0000-0003-0096-0813
Air Force Medical University · CNTang Du Hospital · CNXijing Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myocardial infarction (MI) is the leading cause of premature death among adults. Cardiomyocyte death and dysfunction of the remaining viable cardiomyocytes are the main pathological factors of heart failure after MI. Mitochondrial complexes are emerging as critical mediators for the regulation of cardiomyocyte function. However, the precise roles of mitochondrial complex subunits in heart failure after MI remain unclear. Here, we show that NADH:ubiquinone oxidoreductase core subunit S1 (Ndufs1) expression is decreased in the hearts of heart failure patients and mice with myocardial infarction. Furthermore, we found that cardiac-specific Ndufs1 overexpression alleviates cardiac dysfunction and myocardial fibrosis in the healing phase of MI. Our results demonstrated that Ndufs1 overexpression alleviates MI/hypoxia-induced ROS production and ROS-related apoptosis. Moreover, upregulation of Ndufs1 expression improved the reduced activity of complex I and impaired mitochondrial respiratory function caused by MI/hypoxia. Given that mitochondrial function and cardiomyocyte apoptosis are closely related to heart failure after MI, the results of this study suggest that targeting Ndufs1 may be a potential therapeutic strategy to improve cardiac function in patients with heart failure.

Indexed as

Heart FailureMyocardial InfarctionAnimalsApoptosisDisease Models, AnimalElectron Transport Complex IHypoxiaMiceMice, Inbred C57BLMice, KnockoutMitochondriaMyocytes, CardiacNADH DehydrogenaseReactive Oxygen SpeciesElectron Transport Complex INADH DehydrogenaseNDUFS1 protein, mouseReactive Oxygen Species

Identifiers

PMID35817848
PMCPMC9355970
OpenAlexW4285018947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.